[Harmful effects of common drugs on the visual apparatus. The oligo-elements and chelating agents. A. The oligo-elements].
D001151:Arsenic / Q000009:adverse effects*; D001729:Bismuth / Q000009:adverse effects; D001763:Blepharoptosis / Q000139:chemically induced; D001766:Blindness / Q000139:chemically induced; D003117:Color Vision Defects / Q000139:chemically induced; D003300:Copper / Q000009:adverse effects; D004172:Diplopia / Q000139:chemically induced; D005128:Eye Diseases / Q000139:chemically induced*; D005158:Facial Paralysis / Q000139:chemically induced; D006046:Gold / Q000009:adverse effects; D006801:Humans; D007501:Iron / Q000009:adverse effects; D007634:Keratitis / Q000139:chemically induced; D008628:Mercury / Q000009:adverse effects; D008670:Metals / Q000009:adverse effects*; D009759:Nystagmus, Pathologic / Q000139:chemically induced; D009896:Optic Atrophy / Q000139:chemically induced; D009902:Optic Neuritis / Q000139:chemically induced; D010211:Papilledema / Q000139:chemically induced; D010787:Photosensitivity Disorders / Q000139:chemically induced; D013793:Thallium / Q000009:adverse effects; D014001:Tin / Q000009:adverse effects; D014786:Vision Disorders / Q000139:chemically induced*
D008670:Metals; D014001:Tin; D006046:Gold; D003300:Copper; D013793:Thallium; D007501:Iron; D008628:Mercury; D001151:Arsenic; D001729:Bismuth
Les effets nocifs des médications générales sur l'appareil visuel. Les oligo-elements et chelatuers. A. Les oligo-éléments.